A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 117.06
GOOG 796.97
MSFT 57.25
FB 130.00
BAC 16.56

Recently Added

AMZ 0.00
EAT 50.77
MDM 5.20
ACBI 15.00
QHC 5.85

Gaining Speed

AMZ 0.00
MDRX 12.84
LOW 69.89
T 38.65
GOOG 796.97

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More

Get Alerted When News Hits On This Stock - FREE!